Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)
Esa Jantunen(University of Eastern Finland), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Michel Attal(Université Fédérale de Toulouse Midi-Pyrénées), Nöel Milpied(Hôpital Cardiologique du Haut-Lévêque), Peter Dreger(Heidelberg University), Kirsty Thomson(University College Hospital), P. Wijermans(Haga Hospital), Bernard Rio(Hotel Dieu Hospital), A Schattenberg(Radboud University Nijmegen), A Ferrant(Cliniques Universitaires Saint-Luc), Pierre Biron(Unknown), Charles Crawley(Addenbrooke's Hospital), Hervé Tilly(Centre Virchow-Villermé), J.J. Luan(Hôpital Claude Huriez), Agnès Buzyn(Hôpital Saint-Jacques)
Cited by 58
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|920